| Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes A Erek-Toprak, O Bingol-Ozakpinar, Z Karaca, MA Cikrikcioglu, ... Renal Failure 36 (5), 737-742, 2014 | 29 | 2014 |
| Growth arrest‐specific 6 and cardiometabolic risk factors in patients with psoriasis M Sunbul, Z Cagman, F Gerin, Z Ozgen, E Durmus, D Seckin, S Ahmad, ... Cardiovascular therapeutics 33 (2), 56-61, 2015 | 17 | 2015 |
| Reference intervals for growth arrest-specific 6 protein in adults Z Cagman, O Bingol Ozakpinar, Z Cirakli, A Gedikbasi, P Ay, ... Scandinavian Journal of Clinical and Laboratory Investigation 77 (2), 109-114, 2017 | 5 | 2017 |
| Plasma growth arrest-specific 6 levels in term and preterm newborns E Eksi Alp, N Altinkaya, Z Cagman, F Uras The Journal of Maternal-Fetal & Neonatal Medicine 31 (9), 1151-1155, 2018 | 1 | 2018 |
| C0150: Serum Growth Arrest Protein 6 Levels Before and After Vitamin K Prophylaxis in Term and Preterm Newborns EE Alp, Z Cagman, F Uras, RG Ercan, N Altinkaya Thrombosis Research, S90-S91, 2014 | | 2014 |
| C0554: The Relation Between Growth Arrest-Specific 6 (GAS6) and Conventional Cardiovascular Risk Factors in Patients with Psoriasis F Uras, M Sunbul, Z Cagman, F Gerin, Z Ozgen, E Durmus, D Seckin, ... Thrombosis Research, S54, 2014 | | 2014 |
